126 related articles for article (PubMed ID: 27555084)
1. Aristolochic Acid in the Etiology of Renal Cell Carcinoma.
Hoang ML; Chen CH; Chen PC; Roberts NJ; Dickman KG; Yun BH; Turesky RJ; Pu YS; Vogelstein B; Papadopoulos N; Grollman AP; Kinzler KW; Rosenquist TA
Cancer Epidemiol Biomarkers Prev; 2016 Dec; 25(12):1600-1608. PubMed ID: 27555084
[TBL] [Abstract][Full Text] [Related]
2. Aristolochic acid exposure in Romania and implications for renal cell carcinoma.
Turesky RJ; Yun BH; Brennan P; Mates D; Jinga V; Harnden P; Banks RE; Blanche H; Bihoreau MT; Chopard P; Letourneau L; Lathrop GM; Scelo G
Br J Cancer; 2016 Jan; 114(1):76-80. PubMed ID: 26657656
[TBL] [Abstract][Full Text] [Related]
3. Renal cell carcinomas of chronic kidney disease patients harbor the mutational signature of carcinogenic aristolochic acid.
Jelaković B; Castells X; Tomić K; Ardin M; Karanović S; Zavadil J
Int J Cancer; 2015 Jun; 136(12):2967-72. PubMed ID: 25403517
[TBL] [Abstract][Full Text] [Related]
4. Screening DNA Damage in the Rat Kidney and Liver by Untargeted DNA Adductomics.
Ragi N; Walmsley SJ; Jacobs FC; Rosenquist TA; Sidorenko VS; Yao L; Maertens LA; Weight CJ; Balbo S; Villalta PW; Turesky RJ
Chem Res Toxicol; 2024 Feb; 37(2):340-360. PubMed ID: 38194517
[TBL] [Abstract][Full Text] [Related]
5. Biomonitoring of aristolactam-DNA adducts in human tissues using ultra-performance liquid chromatography/ion-trap mass spectrometry.
Yun BH; Rosenquist TA; Sidorenko V; Iden CR; Chen CH; Pu YS; Bonala R; Johnson F; Dickman KG; Grollman AP; Turesky RJ
Chem Res Toxicol; 2012 May; 25(5):1119-31. PubMed ID: 22515372
[TBL] [Abstract][Full Text] [Related]
6. Exceptionally long-term persistence of DNA adducts formed by carcinogenic aristolochic acid I in renal tissue from patients with aristolochic acid nephropathy.
Schmeiser HH; Nortier JL; Singh R; Gamboa da Costa G; Sennesael J; Cassuto-Viguier E; Ambrosetti D; Rorive S; Pozdzik A; Phillips DH; Stiborova M; Arlt VM
Int J Cancer; 2014 Jul; 135(2):502-7. PubMed ID: 24921086
[TBL] [Abstract][Full Text] [Related]
7. Evidence of exposure to aristolochic acid in patients with urothelial cancer from a Balkan endemic nephropathy region of Romania.
Schmeiser HH; Kucab JE; Arlt VM; Phillips DH; Hollstein M; Gluhovschi G; Gluhovschi C; Modilca M; Daminescu L; Petrica L; Velciov S
Environ Mol Mutagen; 2012 Oct; 53(8):636-41. PubMed ID: 22987305
[TBL] [Abstract][Full Text] [Related]
8. Human formalin-fixed paraffin-embedded tissues: an untapped specimen for biomonitoring of carcinogen DNA adducts by mass spectrometry.
Yun BH; Rosenquist TA; Nikolić J; Dragičević D; Tomić K; Jelaković B; Dickman KG; Grollman AP; Turesky RJ
Anal Chem; 2013 May; 85(9):4251-8. PubMed ID: 23550627
[TBL] [Abstract][Full Text] [Related]
9. Lack of recognition by global-genome nucleotide excision repair accounts for the high mutagenicity and persistence of aristolactam-DNA adducts.
Sidorenko VS; Yeo JE; Bonala RR; Johnson F; Schärer OD; Grollman AP
Nucleic Acids Res; 2012 Mar; 40(6):2494-505. PubMed ID: 22121226
[TBL] [Abstract][Full Text] [Related]
10. Aristolochic Acid-Induced Nephrotoxicity: Molecular Mechanisms and Potential Protective Approaches.
Anger EE; Yu F; Li J
Int J Mol Sci; 2020 Feb; 21(3):. PubMed ID: 32050524
[TBL] [Abstract][Full Text] [Related]
11. Aristolochic acid and the etiology of endemic (Balkan) nephropathy.
Grollman AP; Shibutani S; Moriya M; Miller F; Wu L; Moll U; Suzuki N; Fernandes A; Rosenquist T; Medverec Z; Jakovina K; Brdar B; Slade N; Turesky RJ; Goodenough AK; Rieger R; Vukelić M; Jelaković B
Proc Natl Acad Sci U S A; 2007 Jul; 104(29):12129-34. PubMed ID: 17620607
[TBL] [Abstract][Full Text] [Related]
12. Reduction in the Incidence of Urological Cancers after the Ban on Chinese Herbal Products Containing Aristolochic Acid: An Interrupted Time-Series Analysis.
Jhuang JR; Chiang CJ; Su SY; Yang YW; Lee WC
Sci Rep; 2019 Dec; 9(1):19860. PubMed ID: 31882686
[TBL] [Abstract][Full Text] [Related]
13. Low-Coverage Exome Sequencing Screen in Formalin-Fixed Paraffin-Embedded Tumors Reveals Evidence of Exposure to Carcinogenic Aristolochic Acid.
Castells X; Karanović S; Ardin M; Tomić K; Xylinas E; Durand G; Villar S; Forey N; Le Calvez-Kelm F; Voegele C; Karlović K; Mišić M; Dittrich D; Dolgalev I; McKay J; Shariat SF; Sidorenko VS; Fernandes A; Heguy A; Dickman KG; Olivier M; Grollman AP; Jelaković B; Zavadil J
Cancer Epidemiol Biomarkers Prev; 2015 Dec; 24(12):1873-81. PubMed ID: 26383547
[TBL] [Abstract][Full Text] [Related]
14. Geographic variation of mutagenic exposures in kidney cancer genomes.
Senkin S; Moody S; Díaz-Gay M; Abedi-Ardekani B; Cattiaux T; Ferreiro-Iglesias A; Wang J; Fitzgerald S; Kazachkova M; Vangara R; Le AP; Bergstrom EN; Khandekar A; Otlu B; Cheema S; Latimer C; Thomas E; Atkins JR; Smith-Byrne K; Cortez Cardoso Penha R; Carreira C; Chopard P; Gaborieau V; Keski-Rahkonen P; Jones D; Teague JW; Ferlicot S; Asgari M; Sangkhathat S; Attawettayanon W; Świątkowska B; Jarmalaite S; Sabaliauskaite R; Shibata T; Fukagawa A; Mates D; Jinga V; Rascu S; Mijuskovic M; Savic S; Milosavljevic S; Bartlett JMS; Albert M; Phouthavongsy L; Ashton-Prolla P; Botton MR; Silva Neto B; Bezerra SM; Curado MP; Zequi SC; Reis RM; Faria EF; de Menezes NS; Ferrari RS; Banks RE; Vasudev NS; Zaridze D; Mukeriya A; Shangina O; Matveev V; Foretova L; Navratilova M; Holcatova I; Hornakova A; Janout V; Purdue MP; Rothman N; Chanock SJ; Ueland PM; Johansson M; McKay J; Scelo G; Chanudet E; Humphreys L; de Carvalho AC; Perdomo S; Alexandrov LB; Stratton MR; Brennan P
Nature; 2024 May; 629(8013):910-918. PubMed ID: 38693263
[TBL] [Abstract][Full Text] [Related]
15. Detoxification of aristolochic acid I by O-demethylation: less nephrotoxicity and genotoxicity of aristolochic acid Ia in rodents.
Shibutani S; Bonala RR; Rosenquist T; Rieger R; Suzuki N; Johnson F; Miller F; Grollman AP
Int J Cancer; 2010 Sep; 127(5):1021-7. PubMed ID: 20039324
[TBL] [Abstract][Full Text] [Related]
16. Mutagenicity and DNA adduct formation by aristolochic acid in the spleen of Big Blue® rats.
McDaniel LP; Elander ER; Guo X; Chen T; Arlt VM; Mei N
Environ Mol Mutagen; 2012 Jun; 53(5):358-68. PubMed ID: 22508110
[TBL] [Abstract][Full Text] [Related]
17. Mutational signature of aristolochic acid exposure as revealed by whole-exome sequencing.
Hoang ML; Chen CH; Sidorenko VS; He J; Dickman KG; Yun BH; Moriya M; Niknafs N; Douville C; Karchin R; Turesky RJ; Pu YS; Vogelstein B; Papadopoulos N; Grollman AP; Kinzler KW; Rosenquist TA
Sci Transl Med; 2013 Aug; 5(197):197ra102. PubMed ID: 23926200
[TBL] [Abstract][Full Text] [Related]
18. Identification of a reduction product of aristolochic acid: implications for the metabolic activation of carcinogenic aristolochic acid.
Priestap HA; de los Santos C; Quirke JM
J Nat Prod; 2010 Dec; 73(12):1979-86. PubMed ID: 21141875
[TBL] [Abstract][Full Text] [Related]
19. «Suspects» in etiology of endemic nephropathy: aristolochic acid versus mycotoxins.
Pepeljnjak S; Klarić MŠ
Toxins (Basel); 2010 Jun; 2(6):1414-27. PubMed ID: 22069645
[TBL] [Abstract][Full Text] [Related]
20. Aristolochic Acid Exposure via Dermal Contact or Inhalation of Herbal Powders: Evidence of Occupational Exposure in Herbalists with Urothelial Cancer.
Kwok HC; Chan W
Chem Res Toxicol; 2024 Jun; 37(6):873-877. PubMed ID: 38780306
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
